VANCOUVER, British Columbia, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) today announced the following actions to reinforce its commitment to performance and delivery:
CHICAGO, Dec. 09, 2025 (GLOBE NEWSWIRE) -- The SBB Research Group Foundation is proud to announce the continued success of Esther Park after receiving the STEM Scholarship in 2024. The $2,500 award empowers students to create value for society by pursuing higher learning through interdisciplinary combinations of Science, Technology, Engineering, and Mathematics (STEM).
CAMBRIDGE, United Kingdom, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Cambridge Atomworks is pleased to announce that it has become a member of the WNTI. The World Nuclear Transport Institute (WNTI) is a dedicated membership and non-governmental organisation at the forefront of the global nuclear transport industry, committed to driving the highest standards of safety and…
WASHINGTON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- The Bezos Earth Fund today announced $24.5 million in grants to help park rangers, coastal communities, and local organizations protect key marine areas across the Eastern Tropical Pacific. The new funding will improve on-the-water safety and planning, expand community-led protection in nursery habitats, and strengthen the science used to…
Bethesda, Maryland, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Amid shifting policy landscapes, constrained resources, and evolving community needs, CityHealth’s 2025 Policy Assessment shows that U.S. cities are continuing to drive meaningful health progress through local policy action. This year, 51 of the nation’s 75 largest cities earned an overall medal for the strength and number…
BEIJING, Dec. 08, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that three studies of its novel BCL2 inhibitor, Mesutoclax (ICP-248), were presented at the 67th Annual Meeting of the American Society of Hematology (ASH). Mesutoclax demonstrated remarkable…